2024-08-012025-03-312025-03-31false12742981BROADFIELDS HOLDINGS LTD2025-12-31falseiso4217:GBPxbrli:pure127429812024-07-31127429812025-03-31127429812024-08-012025-03-31127429812023-07-31127429812024-07-31127429812023-08-012024-07-3112742981bus:SmallEntities2024-08-012025-03-3112742981bus:AuditExempt-NoAccountantsReport2024-08-012025-03-3112742981bus:FullAccounts2024-08-012025-03-3112742981bus:PrivateLimitedCompanyLtd2024-08-012025-03-3112742981core:WithinOneYear2025-03-3112742981core:AfterOneYear2025-03-3112742981core:WithinOneYear2024-07-3112742981core:AfterOneYear2024-07-3112742981core:ShareCapital2025-03-3112742981core:SharePremium2025-03-3112742981core:RevaluationReserve2025-03-3112742981core:OtherReservesSubtotal2025-03-3112742981core:RetainedEarningsAccumulatedLosses2025-03-3112742981core:ShareCapital2024-07-3112742981core:SharePremium2024-07-3112742981core:RevaluationReserve2024-07-3112742981core:OtherReservesSubtotal2024-07-3112742981core:RetainedEarningsAccumulatedLosses2024-07-3112742981core:LandBuildings2025-03-3112742981core:PlantMachinery2025-03-3112742981core:Vehicles2025-03-3112742981core:FurnitureFittings2025-03-3112742981core:OfficeEquipment2025-03-3112742981core:NetGoodwill2025-03-3112742981core:IntangibleAssetsOtherThanGoodwill2025-03-3112742981core:ListedExchangeTraded2025-03-3112742981core:UnlistedNon-exchangeTraded2025-03-3112742981core:LandBuildings2024-07-3112742981core:PlantMachinery2024-07-3112742981core:Vehicles2024-07-3112742981core:FurnitureFittings2024-07-3112742981core:OfficeEquipment2024-07-3112742981core:NetGoodwill2024-07-3112742981core:IntangibleAssetsOtherThanGoodwill2024-07-3112742981core:ListedExchangeTraded2024-07-3112742981core:UnlistedNon-exchangeTraded2024-07-3112742981core:LandBuildings2024-08-012025-03-3112742981core:PlantMachinery2024-08-012025-03-3112742981core:Vehicles2024-08-012025-03-3112742981core:FurnitureFittings2024-08-012025-03-3112742981core:OfficeEquipment2024-08-012025-03-3112742981core:NetGoodwill2024-08-012025-03-3112742981core:IntangibleAssetsOtherThanGoodwill2024-08-012025-03-3112742981core:ListedExchangeTraded2024-08-012025-03-3112742981core:UnlistedNon-exchangeTraded2024-08-012025-03-3112742981core:MoreThanFiveYears2024-08-012025-03-3112742981core:Non-currentFinancialInstruments2025-03-3112742981core:Non-currentFinancialInstruments2024-07-3112742981dpl:CostSales2024-08-012025-03-3112742981dpl:DistributionCosts2024-08-012025-03-3112742981core:LandBuildings2024-08-012025-03-3112742981core:PlantMachinery2024-08-012025-03-3112742981core:Vehicles2024-08-012025-03-3112742981core:FurnitureFittings2024-08-012025-03-3112742981core:OfficeEquipment2024-08-012025-03-3112742981dpl:AdministrativeExpenses2024-08-012025-03-3112742981core:NetGoodwill2024-08-012025-03-3112742981core:IntangibleAssetsOtherThanGoodwill2024-08-012025-03-3112742981dpl:GroupUndertakings2024-08-012025-03-3112742981dpl:ParticipatingInterests2024-08-012025-03-3112742981dpl:GroupUndertakingscore:ListedExchangeTraded2024-08-012025-03-3112742981core:ListedExchangeTraded2024-08-012025-03-3112742981dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-08-012025-03-3112742981core:UnlistedNon-exchangeTraded2024-08-012025-03-3112742981dpl:CostSales2023-08-012024-07-3112742981dpl:DistributionCosts2023-08-012024-07-3112742981core:LandBuildings2023-08-012024-07-3112742981core:PlantMachinery2023-08-012024-07-3112742981core:Vehicles2023-08-012024-07-3112742981core:FurnitureFittings2023-08-012024-07-3112742981core:OfficeEquipment2023-08-012024-07-3112742981dpl:AdministrativeExpenses2023-08-012024-07-3112742981core:NetGoodwill2023-08-012024-07-3112742981core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3112742981dpl:GroupUndertakings2023-08-012024-07-3112742981dpl:ParticipatingInterests2023-08-012024-07-3112742981dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3112742981core:ListedExchangeTraded2023-08-012024-07-3112742981dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3112742981core:UnlistedNon-exchangeTraded2023-08-012024-07-3112742981core:NetGoodwill2025-03-3112742981core:IntangibleAssetsOtherThanGoodwill2025-03-3112742981core:LandBuildings2025-03-3112742981core:PlantMachinery2025-03-3112742981core:Vehicles2025-03-3112742981core:FurnitureFittings2025-03-3112742981core:OfficeEquipment2025-03-3112742981core:AfterOneYear2025-03-3112742981core:WithinOneYear2025-03-3112742981core:ListedExchangeTraded2025-03-3112742981core:UnlistedNon-exchangeTraded2025-03-3112742981core:ShareCapital2025-03-3112742981core:SharePremium2025-03-3112742981core:RevaluationReserve2025-03-3112742981core:OtherReservesSubtotal2025-03-3112742981core:RetainedEarningsAccumulatedLosses2025-03-3112742981core:NetGoodwill2024-07-3112742981core:IntangibleAssetsOtherThanGoodwill2024-07-3112742981core:LandBuildings2024-07-3112742981core:PlantMachinery2024-07-3112742981core:Vehicles2024-07-3112742981core:FurnitureFittings2024-07-3112742981core:OfficeEquipment2024-07-3112742981core:AfterOneYear2024-07-3112742981core:WithinOneYear2024-07-3112742981core:ListedExchangeTraded2024-07-3112742981core:UnlistedNon-exchangeTraded2024-07-3112742981core:ShareCapital2024-07-3112742981core:SharePremium2024-07-3112742981core:RevaluationReserve2024-07-3112742981core:OtherReservesSubtotal2024-07-3112742981core:RetainedEarningsAccumulatedLosses2024-07-3112742981core:NetGoodwill2023-07-3112742981core:IntangibleAssetsOtherThanGoodwill2023-07-3112742981core:LandBuildings2023-07-3112742981core:PlantMachinery2023-07-3112742981core:Vehicles2023-07-3112742981core:FurnitureFittings2023-07-3112742981core:OfficeEquipment2023-07-3112742981core:AfterOneYear2023-07-3112742981core:WithinOneYear2023-07-3112742981core:ListedExchangeTraded2023-07-3112742981core:UnlistedNon-exchangeTraded2023-07-3112742981core:ShareCapital2023-07-3112742981core:SharePremium2023-07-3112742981core:RevaluationReserve2023-07-3112742981core:OtherReservesSubtotal2023-07-3112742981core:RetainedEarningsAccumulatedLosses2023-07-3112742981core:AfterOneYear2024-08-012025-03-3112742981core:WithinOneYear2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:CostValuation2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-012025-03-3112742981core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112742981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112742981core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3112742981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3112742981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3112742981bus:Director12024-08-012025-03-3112742981core:FurnitureFittingsToolsEquipment2024-07-3112742981core:FurnitureFittingsToolsEquipment2024-08-012025-03-3112742981core:FurnitureFittingsToolsEquipment2025-03-31127429811bus:Director12024-07-31127429811bus:Director12024-08-012025-03-31127429811bus:Director12025-03-31127429812024-07-31127429812024-08-012025-03-31127429812025-03-31

BROADFIELDS HOLDINGS LTD

Registered Number
12742981
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

BROADFIELDS HOLDINGS LTD
Company Information
for the period from 1 August 2024 to 31 March 2025

Director

Dr. Wayne Kevin Hirschowitz

Registered Address

136-138 High Street
Esher
KT10 9QJ

Registered Number

12742981 (England and Wales)
BROADFIELDS HOLDINGS LTD
Balance Sheet as at
31 March 2025

Notes

31 Mar 2025

31 Jul 2024

£

£

£

£

Fixed assets
Intangible assets3106,667120,000
Tangible assets61,166,9361,235,815
1,273,6031,355,815
Current assets
Stocks73,000-
Debtors8192,911113,008
Cash at bank and on hand376,907320,080
572,818433,088
Creditors amounts falling due within one year9(448,705)(466,231)
Net current assets (liabilities)124,113(33,143)
Total assets less current liabilities1,397,7161,322,672
Creditors amounts falling due after one year10(730,754)(777,083)
Provisions for liabilities12(91,258)-
Net assets575,704545,589
Capital and reserves
Called up share capital11
Profit and loss account575,703545,588
Shareholders' funds575,704545,589
The financial statements were approved and authorised for issue by the Director on 31 December 2025, and are signed on its behalf by:
Dr. Wayne Kevin Hirschowitz
Director
Registered Company No. 12742981
BROADFIELDS HOLDINGS LTD
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 12742981 and registered office address is136-138 High Street, Esher, Surrey, England, KT10 9QJ.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of dental services & the buying and selling of its own real estate is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients.
Interest income
Interest income is recognised using the effective interest rate method.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Land and buildings2-
Plant and machinery-4
Fixtures and fittings-4
Office Equipment-4
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20252024
Average number of employees during the year1413
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 August 24200,000200,000
At 31 March 25200,000200,000
Amortisation and impairment
At 01 August 2480,00080,000
Charge for year13,33313,333
At 31 March 2593,33393,333
Net book value
At 31 March 25106,667106,667
At 31 July 24120,000120,000
4.Useful life of intangible assets
Goodwill is amortised on a straight-line basis over its estimated useful life of 10 years, which is considered appropriate in accordance with HMRC guidelines and standard accounting practice.
5.Impairment of intangible assets
The carrying amount of intangible assets, including goodwill, has been reviewed for indicators of impairment in the current year. Based on this review, the directors have concluded that no impairment charge is required for the year ended 31 March 2025.
6.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 August 241,101,604293,05547,02225,1751,466,856
Additions-8,592-1,69710,289
Disposals(15,664)---(15,664)
At 31 March 251,085,940301,64747,02226,8721,461,481
Depreciation and impairment
At 01 August 2421,273155,65037,31216,806231,041
Charge for year5,20849,2355,8793,18263,504
At 31 March 2526,481204,88543,19119,988294,545
Net book value
At 31 March 251,059,45996,7623,8316,8841,166,936
At 31 July 241,080,331137,4059,7108,3691,235,815
7.Stocks

2025

2024

££
Finished goods3,000-
Total3,000-
8.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables70,77613,409
Amounts owed by associates and joint ventures / participating interests5,319-
Other debtors116,81699,599
Total192,911113,008
As on period ending March 2025 other debtors comprises of below: Prepayments : £21,939.49 (2024: £4,723.35) Directors loan account : £70,918 (2024: £70,918) S455 Tax on overdrawn directors loan : £23,958.11 (2024: £23,958.11)
9.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables107,621135,583
Bank borrowings and overdrafts38,71042,728
Amounts owed to related parties66,959137,958
Taxation and social security194,76198,348
Finance lease and HP contracts36,13641,675
Other creditors4,5189,939
Total448,705466,231
As on period ending March 2025 other creditors comprises of below ; Credit card : £10,999.77 (2024:£13,057.07) Pension payable : £1,369.38 (2024: £1,338.34) Accruals & Deferred income : £3,148.02 (2024: £8,599.95)
10.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts658,247686,649
Other creditors72,50790,434
Total730,754777,083
11.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts108,643132,109
12.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)91,258-
Total91,258-
13.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Dr. Wayne Kevin Hirschowitz70,9180070,918
70,9180070,918
As at the year end, the directors’ loan account was overdrawn by £70,918 (2024: £70,918).
14.Share capital
The issued share capital of the company comprises 100 ordinary shares of £1 each, amounting to a total of £100. The share capital structure remained unchanged from the prior year.
15.Related party transactions
During the period, the company entered into transactions with its directors and other related parties as follows: At the year end, the directors’ loan account was overdrawn by £70,918 (2024: £70,918). The company had transactions with the following related companies during the year: Dr Wayne Hirschowitz Limited – Amount owed by the intercompany: £25.97 (2024: - £67,999) Tanyard & Golding Dental Group – Amount owed to the intercompany: £66,959 (2024: £69,959) Hirschprop Limited – Amount owed by intercompany: £5,293 (2024: £nil) All intercompany balances are interest-free loans, unsecured, and repayable on demand.
16.Change in reporting period and impact on comparability
The company has changed its financial year end. The previous financial statements covered the 12-month period ended 31 July 2024, while the current financial statements cover the 8-month period from 1 August 2024 to 31 March 2025. Consequently, the comparative figures for the prior year are not directly comparable with the current period.